which women should have assessment of bone loss
Last edited 06/2023 and last reviewed 06/2023
- which woman should have a baseline assessment of bone loss
- patients with early invasive breast cancer should have a baseline dual
energy X-ray absorptiometry (DEXA) scan to assess bone mineral density
if they:
- are starting adjuvant aromatase inhibitor treatment
- have treatment-induced menopause
- are starting ovarian ablation/suppression therapy
- do not offer a DEXA scan to patients with early invasive breast cancer who are receiving tamoxifen alone, regardless of pretreatment menopausal status
- patients with early invasive breast cancer should have a baseline dual
energy X-ray absorptiometry (DEXA) scan to assess bone mineral density
if they:
Reference: